Utama › Kanser Serviks › California › Los Angeles
Kajian klinikal Kanser Serviks di Los Angeles, CA
16 kajian untuk Kanser Serviks sedang mencari peserta di lokasi dalam dan sekitar Los Angeles (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Mengambil pesertaFasa 1
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Mengambil pesertaFasa 1/2
- University of Southern California, Los Angeles
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Mengambil pesertaFasa 1
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers
Mengambil peserta
- University of California at Los Angeles, Los Angeles
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- USC/Norris Comprehensive Cancer Center, Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- The Angeles Clinic and Research Institute, Los Angeles
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Mengambil pesertaFasa 1/2
- Los Angeles Cancer Network, Los Angeles
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Mengambil peserta
- UCLA Gynecologic Oncology Clinic, Los Angeles
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Mengambil pesertaFasa 1
- START Los Angeles, Los Angeles
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Ellison Clinic at Saint John's, Los Angeles
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Mengambil pesertaFasa 1
- Ronald Reagan UCLA Medical Center, Los Angeles
- The Regents of the University of California, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
A Study of VET3-TGI in Patients With Solid Tumors
Mengambil pesertaFasa 1
- USC/Norris Comprehensive Cancer Center, Los Angeles
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- University of Southern California, Los Angeles
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Research Site 125, Los Angeles
- Research Site 133, Los Angeles
- Research Site 103, Los Angeles
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Cedars Sinai Medical Center, Los Angeles
A Study of NX-1607 in Adults With Advanced Malignancies
Mengambil pesertaFasa 1
- University of Southern California, Los Angeles
Kajian Kanser Serviks di bandar lain
- Houston, TX34 kajian
- New York City, NY19 kajian
- Nashville, TN19 kajian
- Boston, MA18 kajian
- Arlington, VA16 kajian
- San Antonio, TX14 kajian
- St. Louis, MO13 kajian
- Dallas, TX13 kajian
- Orlando, FL12 kajian
- Chicago, IL12 kajian
- Atlanta, GA11 kajian
- Columbus, OH11 kajian
Kajian lain di Los Angeles
- Kanser Paru-paru Bukan Sel Kecil87 kajian
- Kanser (semua jenis)74 kajian
- Kanser Payudara73 kajian
- Kanser Prostat61 kajian
- Kanser Kolorektal59 kajian
- Kanser Metastatik57 kajian
- Kanser Ovari50 kajian
- Kanser Paru-paru45 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher42 kajian
- Kanser Pankreas35 kajian
- Kanser Endometrium34 kajian
- Melanoma34 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.